Previous Article | Next Article ![]()
Journal of Virology, December 2008, p. 12574-12579, Vol. 82, No. 24
0022-538X/08/$08.00+0 doi:10.1128/JVI.01193-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Histology, Microbiology and Medical Biotechnologies, University of Padua, 35121 Padua, Italy,1 Department of Hematology and Medical Oncology Seragnoli, University of Bologna, 40138 Bologna, Italy,2 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115,3 Department of Microbiology and Immunology and the Cell and Molecular Biology Graduate Program, University of Nevada-Reno, Reno, Nevada 89557,4 Department of Biochemistry and Molecular Biology, Monash University, 3800 Clayton, Victoria, Australia,5 Microbiology Operative Unit, St. Orsola General Hospital, University of Bologna, 40138 Bologna, Italy6
Received 9 June 2008/ Accepted 25 September 2008
The presumed processivity subunit of human cytomegalovirus (HCMV) DNA polymerase, UL44, forms homodimers. The dimerization of UL44 is important for binding to DNA in vitro; however, whether it is also important for DNA replication in a cellular context is unknown. Here we show that UL44 point mutants that are impaired for dimerization, but not for nuclear localization or interaction with the C terminus of the polymerase catalytic subunit, are not capable of supporting HCMV oriLyt-dependent DNA replication in cells. These data suggest that the disruption of UL44 homodimers could represent a novel anti-HCMV strategy.
Published ahead of print on 8 October 2008.
# These two authors contributed equally to this work.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»